Tomorrow, the Senate Health, Education, Labor and Pensions (HELP) Committee will consider S. 625, a bill to transfer regulatory authority over tobacco products and advertising to the Food and Drug Administration. ANA, along with the American Association of Advertising Agencies and the American Advertising Federation, has sent a letter to the committee detailing the constitutional problems with the advertising provisions in the bill.
ANA has sent a letter to the Senate Appropriations Committee in opposition to Senator Sam Brownback
At a hearing held today on children and media violence, ANA filed a policy statement with the Senate Commerce, Science and Transportation Committee expressing our deep concern about any attempt by Congress to regulate violent content and restrict it in a manner similar to indecency.
House Health Subcommittee Strips Drug Safety Bill of Burdensome DTC Restrictions; Full Committee Considers Bill Tomorrow
Yesterday, the Health Subcommittee of the House Energy and Commerce Committee passed an amendment sponsored by Reps. Ed Towns (D-NY) and Steve Buyer (R-IN) removing extremely onerous restrictions on advertising from the drug safety bill.
The Association of National Advertisers (ANA) has urged the Federal Trade Commission (FTC) to reject a proposed change in the Guides Concerning the Use of Endorsements and Testimonials in Advertising.
The Health Subcommittee of the House Energy and Commerce Committee held a legislative hearing today on a number of discussion drafts of pending bills, including the drug safety bill originally introduced by Reps. Ed Markey (D-MA) and Henry Waxman (D-CA), which contains a number of provisions that would severely restrict DTC advertising for new drugs.
The Chairman of the House Energy and Commerce Subcommittee on Health, Congressman Frank Pallone, has released a discussion draft of the drug safety bill. That draft contains five new restrictions on prescription drug advertising to consumers.
The House Energy and Commerce Subcommittee on Health is expected to markup a drug safety bill on Wednesday, June 13, 2007. It is possible that there may be provisions to ban or restrict prescription drug advertising included in the Chairman
Performers' Unions and Advertising Industry Select Booz Allen Hamilton To Conduct Study on Commercials Compensation Models
Screen Actors Guild (SAG), the American Federation of Television and Radio Artists (AFTRA) and the advertising industry
The Institute of Medicine issued a report yesterday calling on the federal government to take various actions to reduce tobacco use, including major restrictions on advertising.
Senator Tom Harkin (D-IA) has reintroduced his HeLP America Act (S. 1342), which contains a number of provisions that impact advertisers.
FCC Chairman Martin and Commissioners Tate and Copps have responded to House Telecommunications and the Internet Subcomittee Chairman Ed Markey's letter urging serious new restrictions on food marketing.
After weeks of negotiations, the Senate yesterday passed the drug safety bill, S.1082, without major new restrictions on direct-to-consumer prescription drug ads.
A summary of events since the adoption of the 2006 Extension Agreement with SAG and AFTRA.
The Federal Communications Commission (FCC) last night released their long awaited report on "Violent Television Programming and Its Impact on Children."
We have learned that the Senate leadership is likely to bring up the drug safety bill (S.1082) as early as next Monday. This bill contains provisions that are an enormous threat to the advertising community.
Yesterday, the Senate Health, Education, Labor and Pensions (HELP) Committee held a markup on S. 1082, the Food and Drug Administration Revitalization Act, which contains a two-year moratorum on advertising for prescription drugs and new government-mandated warnings for ads.
Two important developments on the children's advertising front.
The Senate HELP Committee plans to mark up S. 484, the Enhancing Drug Safety and Innovation Act, on Wednesday, April 18. The bill contains three provisions of concern to the advertising industry.